NCI has issued a report detailing a “scientific framework” for advancing research on pancreatic ductal adenocarcinoma, indicating potential new funding opportunities for genomic studies for early detection of pancreatic cancer.
Human papillomavirus vaccines are underused in the U.S. and need to be made a national public health priority, according to a report from the President's Cancer Panel.
President Barack Obama's $3.9-trillion budget proposal for the 2015 fiscal year would bump NIH funding up to $30.2 billion—a $200 million increase over fiscal 2014—and would include an additional $8 million for NCI, totaling $4.931 billion for the institute.
NIH has launched a systematic examination of its intramural program, which accounts for 11.1 percent of its $30 billion budget.
The contractor running the Frederick National Laboratory for Cancer Research received nearly $300 million from NCI in the 2013 fiscal year, and is slated for an increase, officials said at a recent advisory committee meeting.
Two years ago, NCI officials made a promise to increase the budget of the cooperative groups program by $25.6 million.
Victor Dzau, chancellor of health affairs at Duke University and president and CEO of the Duke University Health System, was named president of the Institute of Medicine.
FDA needs to improve its access to data if it is to manage drug shortages more effectively, the Government Accountability Office concluded.
Enrollment in NCI-sponsored National Clinical Trials Network clinical trials will drop to about 17,500 this fiscal year, the network groups have been told by NCI officials.
NCI has launched a pilot study to assess whether assigning cancer patients treatment based on the genetic characteristics of their disease can improve outcomes for patients with advanced metastatic solid tumors.
